Drugs targeting HTR6 hold promise for treatment of disorders such as anxiety, depression, eating disorders, schizophrenia, and Alzheimer’s disease, and as memory enhancers (13). The gene discussed is HTR6; the disease is early-onset autosomal dominant Alzheimer disease.